The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Sep. 15, 2020
Filed:
Jun. 03, 2016
Applicant:
Orion Corporation, Espoo, FI;
Inventors:
Shouming Wang, Espoo, FI;
Esa Kumpulainen, Helsinki, FI;
Jarmo Pystynen, Espoo, FI;
Antti Pohjakallio, Espoo, FI;
Anssi Haikarainen, Tuusula, FI;
Assignee:
ORION CORPORATION, Espoo, FI;
Primary Examiner:
Int. Cl.
CPC ...
C07D 405/14 (2006.01); C07D 413/14 (2006.01); C07D 417/14 (2006.01); C07D 413/12 (2006.01); C07D 513/04 (2006.01); C07D 405/12 (2006.01); C07D 417/12 (2006.01); A61K 31/496 (2006.01); A61P 25/28 (2006.01); A61P 25/18 (2006.01); A61P 25/24 (2006.01); A61P 25/16 (2006.01);
U.S. Cl.
CPC ...
C07D 405/14 (2013.01); A61K 31/496 (2013.01); A61P 25/16 (2018.01); A61P 25/18 (2018.01); A61P 25/24 (2018.01); A61P 25/28 (2018.01); C07D 405/12 (2013.01); C07D 413/12 (2013.01); C07D 413/14 (2013.01); C07D 417/12 (2013.01); C07D 417/14 (2013.01); C07D 513/04 (2013.01);
Abstract
Compounds of formula I, wherein A is an optionally substituted five-membered unsaturated heterocyclic ring containing 1, 2, or 3 N, O, or S ring heteroatom(s) exhibit alpha2C antagonistic activity and are thus useful for the treatment of diseases or conditions of the peripheric or central nervous system.